ArticleInfection & chemotherapy2026
Characteristics of Drug Resistance Mutations in a Korean HIV/AIDS Cohort, and Risk Factors for Resistance Acquisition in ART-Experienced Patients.
Article in Infection & chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
We aimed to characterize human immunodeficiency virus (HIV) drug-resistance mutations among patients in Korea HIV/acquired immunodeficiency syndrome (AIDS) Cohort. Among 1,579 surveyed between December 2006 and December 2020, 148 had resistance mutations (64 ART-naïve and 84 ART-experienced). The most common mutations in ART-naïve patients were related to non-nucleoside reverse transcriptase inhibitors (V179F/D/E/L; 50.0%), whereas those in ART-experienced were M184V/I (73.8%), conferring resistance to nucleotide reverse transcriptase inhibitors. Multivariate logistic regression identified poor compliance (adjusted odds ratio [aOR], 18.780; 95% confidence interval [CI], 1.883-187.300;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.